medihaler ergotamine
Medihaler Ergotamine (Ergotamine Tartrate) is an ergotamine derivative used to treat Cluster Headache, Migraine Disorders, Postpartum Hemorrhage.
Ergotamine Tartrate · by 3m
Key facts
- Active ingredient
- Ergotamine Tartrate
- Drug class
- Ergotamine Derivative
- Form
- Spray/Inhaler, metered
- Strength
- Ergotamine Tartrate 0.36MG/INH
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- 3m
- FDA application
- NDA012102
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
See how Medihaler Ergotamine ranks — best-rated ergotamine derivative for:
Dosage forms
Spray/Inhaler, metered
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Medihaler Ergotamine treat?
- Medihaler Ergotamine (Ergotamine Tartrate) may be used to treat cluster headache, migraine disorders, postpartum hemorrhage, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Medihaler Ergotamine?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Medihaler Ergotamine. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Medihaler Ergotamine?
- Medihaler Ergotamine is marketed by 3m. You can see 3m's full profile, rating, and other products on pharmaranks.
- Is Medihaler Ergotamine a brand-name or generic drug?
- Medihaler Ergotamine is a brand-name product with the active ingredient Ergotamine Tartrate.
- Is Medihaler Ergotamine available over the counter?
- No. Medihaler Ergotamine is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Medihaler Ergotamine come in?
- Medihaler Ergotamine is currently marketed as spray/inhaler, metered, per the FDA's National Drug Code Directory.
- What class of drug is Medihaler Ergotamine?
- Medihaler Ergotamine is classified as ergotamine derivative, per the FDA's Established Pharmacologic Class.
- Is Medihaler Ergotamine FDA-registered?
- Medihaler Ergotamine is on record with the U.S. FDA under application number NDA012102. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about ERGOTAMINE TARTRATE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 214 reports naming ERGOTAMINE TARTRATE — the active ingredient in Medihaler Ergotamine, and the FDA flagged 95% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- insomnia38 reports
- paraesthesia31 reports
- therapy partial responder25 reports
- ergot poisoning20 reports
- headache19 reports
- migraine17 reports
- pain in extremity16 reports
- pyrexia14 reports
Read these as a signal, not a rate. A report does not mean ERGOTAMINE TARTRATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
brekiya (autoinjector)
Dihydroergotamine Mesylate
atzumi
Dihydroergotamine Mesylate
dihydroergotamine mesylate
Dihydroergotamine Mesylate
migranal
Dihydroergotamine Mesylate
trudhesa
Dihydroergotamine Mesylate
Compare Medihaler Ergotamine head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
medihaler ergotamine
New